塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/09/07 | 6,420 | 6,452 | 6,366 | 6,437 | +17 | +0.3% | 993,500 |
2018/09/06 | 6,460 | 6,463 | 6,410 | 6,420 | -75 | -1.2% | 938,500 |
2018/09/05 | 6,450 | 6,529 | 6,416 | 6,495 | -2 | ±0% | 1,285,400 |
2018/09/04 | 6,491 | 6,500 | 6,448 | 6,497 | -1 | ±0% | 882,100 |
2018/09/03 | 6,400 | 6,513 | 6,393 | 6,498 | +42 | +0.7% | 962,800 |
2018/08/31 | 6,358 | 6,467 | 6,352 | 6,456 | +103 | +1.6% | 1,649,300 |
2018/08/30 | 6,405 | 6,405 | 6,323 | 6,353 | -13 | -0.2% | 1,043,200 |
2018/08/29 | 6,336 | 6,404 | 6,334 | 6,366 | +59 | +0.9% | 1,274,800 |
2018/08/28 | 6,346 | 6,366 | 6,292 | 6,307 | -38 | -0.6% | 1,241,000 |
2018/08/27 | 6,288 | 6,359 | 6,274 | 6,345 | +87 | +1.4% | 1,124,800 |
2018/08/24 | 6,222 | 6,265 | 6,189 | 6,258 | +9 | +0.1% | 1,086,300 |
2018/08/23 | 6,209 | 6,288 | 6,197 | 6,249 | +86 | +1.4% | 1,288,400 |
2018/08/22 | 6,207 | 6,218 | 6,142 | 6,163 | -48 | -0.8% | 1,072,300 |
2018/08/21 | 6,180 | 6,225 | 6,128 | 6,211 | +62 | +1% | 1,130,100 |
2018/08/20 | 6,189 | 6,189 | 6,111 | 6,149 | -40 | -0.6% | 773,400 |
2018/08/17 | 6,148 | 6,209 | 6,143 | 6,189 | +46 | +0.7% | 979,800 |
2018/08/16 | 6,116 | 6,158 | 6,036 | 6,143 | +4 | +0.1% | 1,191,700 |
2018/08/15 | 6,051 | 6,144 | 6,030 | 6,139 | +66 | +1.1% | 1,050,500 |
2018/08/14 | 5,994 | 6,076 | 5,976 | 6,073 | +103 | +1.7% | 1,114,700 |
2018/08/13 | 6,011 | 6,016 | 5,940 | 5,970 | -70 | -1.2% | 1,037,500 |
2018/08/10 | 6,084 | 6,090 | 6,026 | 6,040 | -17 | -0.3% | 1,147,900 |
2018/08/09 | 6,037 | 6,072 | 6,016 | 6,057 | +20 | +0.3% | 760,900 |
2018/08/08 | 6,046 | 6,077 | 6,011 | 6,037 | -9 | -0.1% | 828,000 |
2018/08/07 | 6,010 | 6,064 | 5,992 | 6,046 | +13 | +0.2% | 808,400 |
2018/08/06 | 6,050 | 6,079 | 6,017 | 6,033 | -18 | -0.3% | 861,800 |
2018/08/03 | 6,074 | 6,089 | 6,020 | 6,051 | -18 | -0.3% | 975,700 |
2018/08/02 | 6,174 | 6,210 | 6,030 | 6,069 | -89 | -1.4% | 1,310,000 |
2018/08/01 | 6,129 | 6,174 | 6,104 | 6,158 | +82 | +1.3% | 1,763,800 |
2018/07/31 | 5,968 | 6,099 | 5,945 | 6,076 | +160 | +2.7% | 3,112,100 |
2018/07/30 | 5,690 | 5,981 | 5,656 | 5,916 | +161 | +2.8% | 2,434,900 |
2018/07/27 | 5,760 | 5,775 | 5,721 | 5,755 | +26 | +0.5% | 784,600 |
2018/07/26 | 5,677 | 5,729 | 5,654 | 5,729 | +79 | +1.4% | 901,600 |
2018/07/25 | 5,742 | 5,756 | 5,639 | 5,650 | -45 | -0.8% | 958,400 |
2018/07/24 | 5,776 | 5,800 | 5,689 | 5,695 | -27 | -0.5% | 937,300 |
2018/07/23 | 5,752 | 5,781 | 5,702 | 5,722 | -29 | -0.5% | 824,700 |
2018/07/20 | 5,741 | 5,787 | 5,702 | 5,751 | +16 | +0.3% | 1,044,700 |
2018/07/19 | 5,765 | 5,778 | 5,731 | 5,735 | +21 | +0.4% | 987,900 |
2018/07/18 | 5,752 | 5,796 | 5,714 | 5,714 | +26 | +0.5% | 1,011,400 |
2018/07/17 | 5,553 | 5,733 | 5,550 | 5,688 | +136 | +2.4% | 1,423,300 |
2018/07/13 | 5,536 | 5,595 | 5,507 | 5,552 | +13 | +0.2% | 1,366,500 |
2018/07/12 | 5,575 | 5,606 | 5,529 | 5,539 | +23 | +0.4% | 1,081,600 |
2018/07/11 | 5,590 | 5,592 | 5,495 | 5,516 | -89 | -1.6% | 1,169,100 |
2018/07/10 | 5,595 | 5,648 | 5,581 | 5,605 | +8 | +0.1% | 1,045,400 |
2018/07/09 | 5,566 | 5,626 | 5,559 | 5,597 | +38 | +0.7% | 735,100 |
2018/07/06 | 5,480 | 5,604 | 5,474 | 5,559 | +106 | +1.9% | 1,420,500 |
2018/07/05 | 5,519 | 5,529 | 5,410 | 5,453 | -42 | -0.8% | 1,510,500 |
2018/07/04 | 5,468 | 5,515 | 5,437 | 5,495 | +3 | +0.1% | 815,800 |
2018/07/03 | 5,507 | 5,535 | 5,437 | 5,492 | +20 | +0.4% | 1,485,200 |
2018/07/02 | 5,648 | 5,651 | 5,469 | 5,472 | -219 | -3.8% | 1,403,300 |
2018/06/29 | 5,672 | 5,699 | 5,613 | 5,691 | +59 | +1% | 1,108,800 |
1701~
1750
件表示中 / 3773件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 255,000円 | +20.9% | +10.6% | 2.59% | 12.06倍 | 1.59倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 776,600円 | +2.2% | +28.0% | 1.80% | 12.43倍 | 1.51倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 162,000円 | +0.9% | +380.2% | 4.81% | 22.32倍 | 1.92倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
協和キリン | 254,500円 | -3.5% | -11.3% | 2.36% | 23.37倍 | 1.58倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
エーザイ | 453,800円 | +0.1% | -3.4% | 3.53% | 30.85倍 | 1.52倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム